26 May 2013
Keywords: expanded, indication, gsk, bexxar, glaxosmithkline, says, food
Article | 10 January 2005
GlaxoSmithKline says that the US Food and Drug Administration has approved a supplemental Biologics License Application for the expanded
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2005
24 May 2013
© 2013 thepharmaletter.com